Hexal AG

Industry / private company


Location: Holzkirchen, Germany (DE) DE

ISNI: 0000000406294302

ROR: https://ror.org/0013shd50

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cardiovascular Safety of GnRH Agonist-Based Androgen Deprivation Therapy in a Real-World Setting: Results from a Prospective Cohort Study (LEAN) (2025) Schmitz-Dräger BJ, Bismarck E, Ebert T, Starlinger R, Dienes K, Ottillinger B, Goebell P, et al. Journal article Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors (2023) Muth KN, Rech J, Losch FO, Hörning A Journal article, Review article Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study (2019) Combe C, Mann J, Goldsmith D, Dellanna F, Zaoui P, London G, Denhaerynck K, et al. Journal article Evaluation of the safety and immunogenicity of subcutaneous HX575 epoetin alfa in the treatment of anemia associated with chronic kidney disease in predialysis and dialysis patients? (2017) Casadevall N, Dobronravov V, Eckardt KU, Ertürk S, Martynyuk L, Schmitt S, Schaffar G, et al. Journal article Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis (2016) Kleist C, Mohr E, Gaikwad S, Dittmar L, Kuerten S, Platten M, Mier W, et al. Journal article